| Capital Vision Center Pc | |
|
153 Manchester St, Concord, NH 03301-5142 | |
| (603) 226-0855 | |
| (603) 226-0981 |
| Full Name | Capital Vision Center Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 153 Manchester St, Concord, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467659185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Brian J Weber |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215941604 PECOS PAC ID: 5991722241 Enrollment ID: I20051026001119 |
News Archive
As COVID-19 cases surged this spring, the pandemic led some people more than others to ponder their own mortality. A new study in China and the United States suggests that these people were the ones who showed the highest levels of stress and the least engagement at work.
On September 30, 2014, in Washington, DC, higher education and health leaders will release a report that is the first to examine nationwide the impact and use of holistic review-a university admissions process that assesses an applicant's unique experiences alongside traditional measures of academic achievement such as grades and test scores-for students pursuing careers in the health professions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.
Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.
› Verified 5 days ago
| Provider Name | Eugene S Baylus |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255366092 PECOS PAC ID: 5799707220 Enrollment ID: I20051228000253 |
News Archive
As COVID-19 cases surged this spring, the pandemic led some people more than others to ponder their own mortality. A new study in China and the United States suggests that these people were the ones who showed the highest levels of stress and the least engagement at work.
On September 30, 2014, in Washington, DC, higher education and health leaders will release a report that is the first to examine nationwide the impact and use of holistic review-a university admissions process that assesses an applicant's unique experiences alongside traditional measures of academic achievement such as grades and test scores-for students pursuing careers in the health professions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.
Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.
› Verified 5 days ago
| Provider Name | Tyler John Weber |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1164983672 PECOS PAC ID: 9436486271 Enrollment ID: I20190816000210 |
News Archive
As COVID-19 cases surged this spring, the pandemic led some people more than others to ponder their own mortality. A new study in China and the United States suggests that these people were the ones who showed the highest levels of stress and the least engagement at work.
On September 30, 2014, in Washington, DC, higher education and health leaders will release a report that is the first to examine nationwide the impact and use of holistic review-a university admissions process that assesses an applicant's unique experiences alongside traditional measures of academic achievement such as grades and test scores-for students pursuing careers in the health professions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.
Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.
› Verified 5 days ago
| Provider Name | Karl Cameron Engelhart |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1033766647 PECOS PAC ID: 4880926831 Enrollment ID: I20191024002141 |
News Archive
As COVID-19 cases surged this spring, the pandemic led some people more than others to ponder their own mortality. A new study in China and the United States suggests that these people were the ones who showed the highest levels of stress and the least engagement at work.
On September 30, 2014, in Washington, DC, higher education and health leaders will release a report that is the first to examine nationwide the impact and use of holistic review-a university admissions process that assesses an applicant's unique experiences alongside traditional measures of academic achievement such as grades and test scores-for students pursuing careers in the health professions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.
Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Capital Vision Center Pc 153 Manchester St, Concord, NH 03301-5142 Ph: () - | Capital Vision Center Pc 153 Manchester St, Concord, NH 03301-5142 Ph: (603) 226-0855 |
News Archive
As COVID-19 cases surged this spring, the pandemic led some people more than others to ponder their own mortality. A new study in China and the United States suggests that these people were the ones who showed the highest levels of stress and the least engagement at work.
On September 30, 2014, in Washington, DC, higher education and health leaders will release a report that is the first to examine nationwide the impact and use of holistic review-a university admissions process that assesses an applicant's unique experiences alongside traditional measures of academic achievement such as grades and test scores-for students pursuing careers in the health professions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.
Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.
› Verified 5 days ago
Mr. Charles Edward Daniels Iii, OD Optometrist Medicare: Medicare Enrolled Practice Location: 8 N State St, Concord, NH 03301 Phone: 603-225-2512 Fax: 603-225-3249 | |
Rachel Roman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 304 Sheep Davis Rd, Concord, NH 03301 Phone: 603-226-1255 | |
Dr. Karl Cameron Engelhart, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 153 Manchester St, Concord, NH 03301 Phone: 603-226-0855 Fax: 603-226-0981 | |
Dr. Anthony N Sacco, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 21 Green St, Concord, NH 03301 Phone: 603-224-0971 | |
Douglas P Benoit, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 | |
Ziwei Wu, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-224-2020 | |
Dr. Abbie Louise Martin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8 N State St, Concord, NH 03301 Phone: 603-225-2512 |